Hjem › Makuladegeneration › Florida
Makuladegeneration kliniske forsøg i Florida
14 studier for Makuladegeneration søger deltagere på steder i Florida.
Byer i Florida
- Pensacola5 studier
- Tampa5 studier
- Fort Lauderdale5 studier
- Orlando5 studier
- Sarasota4 studier
- Jacksonville4 studier
- St. Petersburg4 studier
- Gainesville3 studier
- Lakeland3 studier
- Cape Coral3 studier
Officiel studietekst (engelsk)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Florida Eye Clinic (Site 130), Altamonte Springs
- Retina Group of Florida (Site 070), Fort Lauderdale
- Vitreo Retinal Associates, Gainesville
- og 10 flere
RekruttererFase 2/3
Alder 50 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina Group of Florida, Fort Lauderdale
- VitreoRetinal Associates, PA, Gainesville
- Retina Specialty Institute, Pensacola
- og 1 flere
RekruttererFase 2/3
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Advanced Retina Institute-Ophthalmology, Bonita Springs
- Advanced Research, Coral Springs
- Retina Group of Florida, Fort Lauderdale
- og 11 flere
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
- Advanced Retina Institute, Bonita Springs
RekruttererFase 2
Alder 50 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07811726Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Florida Retina Institute, Orlando
- Retina Specialty Institute, Pensacola
- Retina Group of Florida, Sarasota
- og 1 flere
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Retina Specialty Institute, Pensacola
RekruttererFase 1
Alder 50 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT03178149A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Florida Health - UF Health Jacksonville, Jacksonville
- University of Miami Health System - Bascom Palmer Eye Institute, Miami
RekruttererObservationsstudie
Alder 6 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Retina Group of Florida, Fort Lauderdale
- Vitreo Retinal Associates, Gainesville
- Florida Eye Associates, Melbourne
- og 2 flere
RekruttererFase 1/2
Alder 50 og opefter · Alle køn · Opdateret 21. aug. 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Retina Group of Florida, Fort Myers
- Florida Retina Institute, Orlando
- Retina Group of Florida (Site 065), Sarasota
- og 1 flere
RekruttererFase 2/3
Alder 50 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07496567Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 124, Deerfield Beach
- Adverum site 176, Fort Lauderdale
- Adverum site 168, Jacksonville
RekruttererFase 2
Alder 50 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07630649Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT03011541Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- ClearVista Clinical Research, Hudson
- Florida Retina Institute, Orlando
- Retina Specialty Institute, Pensacola
- og 3 flere
RekruttererFase 3
Alder 50 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT07064759Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
- CBCC Global Research Site:006, Deerfield Beach
RekruttererFase 1
Alder 50 og opefter · Alle køn · Opdateret 7. feb. 2025 · NCT06132035Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Sarasota Retina Institute, Sarasota
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 3. dec. 2024 · NCT05438732Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.